Rejoinder: response-adaptive randomization in clinical trials

DOI10.1214/23-sts865rejOpenAlexW4379414949MaRDI QIDQ6111470

David S. Robertson, Kim May Lee, Sofía S. Villar, Boryana C. López-Kolkovska

Publication date: 7 July 2023

Published in: Statistical Science (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1214/23-sts865rej

Mathematics Subject Classification ID

Statistics (62-XX)

Cites Work

• Unnamed Item
• Unnamed Item
• Multi-armed bandit models for the optimal design of clinical trials: benefits and challenges
• Bayesian doubly adaptive randomization in clinical trials
• A Bayesian adaptive design for clinical trials in rare diseases
• Response‐adaptive randomization for multi‐arm clinical trials using the forward looking Gittins index rule
• Using a dose‐finding benchmark to quantify the loss incurred by dichotomization in Phase II dose‐ranging studies
• Bayesian adaptive bandit-based designs using the Gittins index for multi-armed trials with normally distributed endpoints
• Optimal adaptive randomized designs for clinical trials
• Bayesian Response-Adaptive Designs for Basket Trials
• Response-adaptive randomization in clinical trials: from myths to practical considerations

This page was built for publication: Rejoinder: response-adaptive randomization in clinical trials